<DOC>
	<DOCNO>NCT01616693</DOCNO>
	<brief_summary>The percentage participant serologic immune response ( seroconversion four-fold rise rotavirus IgA antibody ) rotavirus vaccine 14 week age among infant receive zinc probiotic supplement least 15 % high significantly well infant receive placebo zinc probiotic supplement .</brief_summary>
	<brief_title>Zinc and/or Probiotic Supplementation Rotavirus Oral Polio Virus Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Infants 3541 day old Live area surveillance Current weight â‰¥3.2 kg No syndromic evidence immunocompromise determine medical doctor No prior illness require hospitalization No current medical condition determine medical doctor precludes study involvement Available follow duration study ( approximately 14 week age ) Parents/guardians infant able understand follow study procedure agree participate study provide sign informed consent Child history atopic symptom Child know digestive system defect Child history chronic diarrhea Child major congenital anomaly Child receive prior dose rotavirus vaccine Child receive prior dose polio vaccine ( beyond birth dose )</criteria>
	<gender>All</gender>
	<minimum_age>5 Weeks</minimum_age>
	<maximum_age>16 Weeks</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>rotavirus</keyword>
	<keyword>polio</keyword>
	<keyword>zinc supplement</keyword>
	<keyword>probiotic supplement</keyword>
	<keyword>rotavirus vaccine shed</keyword>
</DOC>